Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adrian Thomas

Orthopaedic Surgery of the Spine Bedford, NH Medical Doctor

NPI 1386801132 CMS profile 1029215

4 Hawthorne Dr, Bedford, NH 03110

Open in the dashboard

General payments

$943,776

1,016 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adrian Thomas of Bedford, NH is reported in the CMS Open Payments database as having received $943,776 across 1,016 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $161,824 170
2024 General $175,335 181
2023 General $158,322 160
2022 General $177,531 207
2021 General $97,413 104
2020 General $65,682 64
2019 General $107,669 130

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adrian Thomas
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Adrian Thomas were reported at $161,824. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Adrian Thomas Orthopaedic Surgery of the Spine median Middle half National median
2019 $107,669 $2,106 $337–$18,608 $163
2020 $65,682 $1,213 $156–$15,082 $114
2021 $97,413 $1,834 $271–$15,617 $132
2022 $177,531 $2,015 $320–$17,036 $149
2023 $158,322 $1,925 $336–$14,599 $160
2024 $175,335 $2,110 $341–$12,483 $164
2025 $161,824 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $764,130 772 payments
  2. Medtronic USA, Inc. $170,812 153 payments
  3. Alphatec Spine, Inc $5,044 21 payments
  4. Stryker Corporation $1,596 36 payments
  5. NuVasive, Inc. $1,028 6 payments
  6. Xtant Medical Inc $192 3 payments
  7. Precision Spine, Inc. $159 1 payment
  8. Bioventus LLC $144 2 payments
  9. CTL Medical Corporation $94 2 payments
  10. AbbVie, Inc. $68 2 payments
  11. Other $509 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $766,520 139 payments
  2. Travel and Lodging $94,853 396 payments
  3. Consulting Fee $57,328 20 payments
  4. Food and Beverage $25,075 461 payments
Products named General payments · program years 2019–2025
  1. PIVOX Oblique Lateral Spinal System Tl $155,088 113 payments
  2. CD HORIZON SPINAL SYSTEM $117,930 118 payments
  3. CLYDESDALE PTC SPINAL SYSTEM $100,782 87 payments
  4. PIVOX Oblique Lateral Spinal System Tl $76,344 50 payments
  5. STEALTHSTATION S8 PLATFORM $63,167 65 payments
  6. ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY $48,636 63 payments
  7. MAZOR X SYSTEM $32,216 45 payments
  8. DIVERGENCE-L $23,260 29 payments
  9. STEALTH AUTOGUIDE SYSTEM $22,081 22 payments
  10. CRESCENT $20,790 1 payment
  11. Other $151,458 284 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

27

Median for Orthopedic Surgery: 203

Drug cost

$95

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 14 $63
Meloxicam Generic 13 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$78,025

Medicare's payments for the services billed

Medicare patients

193

Average age 71

Services billed

1,296

92 women, 101 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 68%
Depression 27%
Ischemic heart disease 26%
Diabetes 23%
Chronic kidney disease 19%
Atrial fibrillation 16%
Osteoporosis 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,016 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in New Hampshire

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record